Pfizer Didn't Disclose Viagra's Melanoma Risks, MDL Says

Law360, New York (September 9, 2016, 7:19 PM EDT) -- Consumers in California multidistrict litigation against Pfizer Inc. accused the pharmaceutical giant Friday of aggressively promoting Viagra without admitting that research has linked use of the blockbuster erectile dysfunction drug to an increased risk of developing melanoma.

The consumers laid out their claims in a master complaint that alleges Pfizer knew or should have known about the health risks associated with Viagra and Revatio, which is the same substance sold under a different name for treating a lung condition, but didn't disclose this information on its labels or in its advertisements.

"Pfizer purposefully downplayed, understated and outright ignored the melanoma-related health...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!